Digital Health Ecosystem - TagOnline

A developer of novel electronic media therapies designed for the treatment of Amblyopia and other ocular diseases in adults and children.

Offering Types
  • Patient Engagement

Locations

Corporate HQ - Atlanta

  • Corporate HQ

Atlanta, GA


CEO Contact Information

N/A
N/A

N/A

Last updated on 07/28/2022
Verified by Amblyotech (acquired by Novartis) On 07/28/2022